A research study titled, “Craniomaxillofacial Devices Market by Product, Application, and Material - Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the craniomaxillofacial devices market is projected to be around $3 billion by 2025.
Craniomaxillofacial devices are used to treat injuries of the mouth, skull, face, jaws, and related structures. Any CMF surgery results in a deficiency of natural soft tissue and bone. Thus, this will need an implant or a graft for wound closure and optimal healing. Blow to the head is the most common injury. Annually, 7 million head injuries occur in the U.S. Nearly half of all head injuries are due to motor vehicle accidents. Another common type of head and facial injury is sport injury. CMF injuries range from a minor damage to the scalp (including abrasions and lacerations) to serious brain injury.
Elderly population is highly susceptible to CMF injuries due to falling. For instance, in the U.S., the number of older people (aged 65 and older) is expected to reach 98 million by 2060 from 46 million in 2016 (Source: The Population Reference Bureau Report on “Aging in the United States”). Moreover, increased life expectancy will further contribute to the market growth. The average life expectancy in the U.S. increased to 79 years in 2013 from 68 years in 1950. Thus, the rapidly aging population will accelerate the demand for CMF devices in near future. Such high target population will bring in ample growth opportunities for the development of advanced CMF products.
Rise in number of craniomaxillofacial surgeries, rapidly aging population as it is more prone to fractures, increasing adoption of advanced products, and growing demand for minimal invasive procedures are set to drive the global market for craniomaxillofacial devices. Growing number of sports-related injuries and advent of new technologies with proven clinical outcomes will further stimulate the growth of the market. However, the CMF surgery is associated with a risk of major complications which will hamper the market growth. Moreover, high cost of surgery and multiple surgery requirements are set to further challenge the growth of craniomaxillofacial devices market.
CMF plate and screw fixation segment held the largest share of the products market in 2016 owing to its immense utility in various surgical procedures such as deformity correction, pediatric surgeries, orthognathic surgery, and tumor removal. Temporomandibular joint (TMJ) replacement segment is expected to exhibit fastest growth during the forecast period owing to rise in number of cosmetic surgeries such as jaw replacement and chin augmentation.
Metal segment held the largest share of the materials market in 2016 as the metal implants are cheaper than other bioabsorbable materials and they provide rigid support to the fractures. Bioabsorbable materials segment is anticipated to show favorable growth during the forecast period as their usage nullifies the need for second surgery, generally required in case of metallic implants.
U.S. dominated the North American craniomaxillofacial devices market in 2016 owing to rising incidence of facial deformities and facial fractures. Moreover, rising demand for minimally invasive surgeries in the country will largely contribute to the market growth during the forecast period. Emerging markets such as China and India in the Asia-Pacific region are expected to register favorable growth during the forecast period due to increasing patient awareness levels and presence of unmet medical needs in developing nations.
Development of cost effective craniomaxillofacial devices with enhanced minimally invasive capabilities will facilitate the future growth of the global craniomaxillofacial devices market as such devices will generate lucrative demand in the emerging markets that are price sensitive. The key players in the craniomaxillofacial devices market emphasize on product development and geographical expansion to ensure competitive advantage over other players.
Some of the major players operating in the global craniomaxillofacial devices market are Medartis AG, TMJ Concepts, B. Braun Melsungen AG, Medtronic plc, DePuySynthes (a subsidiary of Johnson & Johnson Services, Inc.), OsteoMed, Zimmer Biomet Holdings, Inc., Stryker Corporation and KLS Martin L.P.
Browse full research report with TOC on “Craniomaxillofacial Devices Market by Product, Application, and Material - Global Industry Analysis and Forecast to 2025” at:
https://www.crystalmarketresearch.com/report/craniomaxillofacial-devices-market
Key Findings of the Research Study:
The global craniomaxillofacial devices market is expected to be around $3 billion by 2027. Craniomaxillofacial (CMF) is a discipline of orthopedic surgery that deals with all the aspects related to facial and skull disorders. Craniomaxillofacial procedures are usually performed to treat severe injuries to the facial and cranial bones.